Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Subconjunctival Bevacizumab Injection for the Prevention of Bleb Vascularization Post Trabeculectomy

NCT00854529 is registered in ClinicalTrials.gov with Rabin Medical Center as lead sponsor.

NCT NCT00854529
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00854529 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Subconjunctival Bevacizumab Injection for the Prevention of Bleb Vascularization Post Trabeculectomy
Lead sponsor
Rabin Medical Center
Phase
Phase 2
Overall status
Unknown status
Start date
April 30, 2009
Completion date
October 31, 2011
Enrollment
60 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

bleb fibrosis, bleb vascularity, trabeculectomy failure